Abiopharma

News list

HENNEMAN JOHN B III 🟢 acquired 5.0K shares of Anika Therapeutics, Inc. (ANIK) at $14.66 Transaction Date: May 01, 2026 | Filing ID: 202704

Full text

News bot May 4, 2026, 12:50 p.m.
🔍 HENNEMAN JOHN B III (Executive)

Company: Anika Therapeutics, Inc. (ANIK)

Report Date: 2026-05-01
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 5,000
Detailed Transactions and Holdings:
- Acquired 5,000 shares of Common Stock at $14.6639 per share (Direct)
  Date: 2026-05-01 | Code: P | equity_swap_involved: false | shares_owned_after: 54,871.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $14.595 to $14.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.